⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IONS News
Ionis Pharmaceuticals, Inc. Common Stock
Form 8-K
sec.gov
IONS
Liberty All-Star ® Growth Fund, Inc. March 2026 Monthly Update
businesswire.com
NVDA
AAPL
MSFT
GOOGL
AMZN
CW
OLLI
MPWR
TPR
LLY
CASY
LNG
DB
IONS
IPGP
MU
TER
ABBV
COMP
DHR
PSTG
VRTX
Oligonucleotides Market Research and Competitive Landscape Report 2026 Featuring Novartis, Astellas, Alnylam Pharmaceuticals, Ionis Pharmaceuticals
globenewswire.com
NVS
ALNY
IONS
FDA Approves High Dose Regimen of SPINRAZA® for Spinal Muscular Atrophy, Reflecting Progress Made Possible Through Decades of MDA Supported Research
globenewswire.com
BIIB
IONS
FDA Approves New High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy
globenewswire.com
IONS
BIIB
EMA validates indication extension application for Tryngolza® (olezarsen) for the treatment of severe hypertriglyceridemia (sHTG)
prnewswire.com
IONS
Kardigan Announces Positive Phase 2 Data for Tonlamarsen in Patients with Uncontrolled Hypertension Presented as Late-Breaker at ACC.26 and Simultaneously Published in JACC
businesswire.com
IONS
BMY
SNY
n-Lorem Publishes Commentary Offering Insight into Potential Commercialization Strategies for Nano-rare Medicines
businesswire.com
IONS
National Triglyceride Alliance Celebrates One Year of Impact and Recognizes National Triglycerides Day
prnewswire.com
IONS
ARWR
AMRN
Kardigan Announces Multiple Presentations at ACC.26 from its Late-Stage Portfolio of Personalized Cardiovascular Medicines
businesswire.com
IONS
SNY
BMY